Stock listing

Shanghai:600671 Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd (天目药业) 股价

Follow Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd into a list and get an email when it puts out news.

Share price · SSE:600671

¥19.23 CNY +0.32 (+1.7%)

Close on Oct 22, 2026

Past year +1.3% · daily closes, Oct 22, 2025 – Oct 22, 2026, adjusted for splits
Day range
¥18.61 – ¥19.29 CNYOct 22, 2026
Volume
2.21M sharesOct 22, 2026
Market cap
¥2.34B CNYAt the close on Oct 22, 2026 · price × 121.8M shares outstanding
52-week range
¥15.70 – ¥24.25 CNYLowest and highest trades, Oct 23, 2025 – Oct 22, 2026
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd logo

Daily closes

Last 3 months, Jul 22, 2026 – Oct 22, 2026 · SSE:600671 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥19.23+0.32+1.7%¥18.97¥19.29¥18.612,206,989
¥18.91-0.17-0.9%¥19.41¥19.44¥18.882,011,389
¥19.08+0.17+0.9%¥18.80¥19.50¥18.753,773,695
¥18.91-1.39-6.8%¥19.00¥19.57¥18.277,813,325
¥20.30-2.26-10.0%¥22.77¥23.88¥20.308,865,400
¥22.56-0.16-0.7%¥22.38¥23.30¥22.202,620,689
¥22.72-0.47-2.0%¥22.97¥23.35¥22.302,607,800
¥23.19+0.89+4.0%¥22.23¥23.44¥21.823,156,220
¥22.30-0.62-2.7%¥22.62¥23.20¥22.142,063,156
¥22.92+0.05+0.2%¥22.84¥22.95¥21.613,192,426
¥22.87+1.08+5.0%¥21.68¥23.23¥21.683,393,700
¥21.79+0.17+0.8%¥21.61¥21.90¥21.551,515,000
¥21.62-0.22-1.0%¥21.86¥22.21¥21.602,144,700
¥21.84-1.19-5.2%¥23.10¥23.12¥21.703,187,900
¥23.03-0.27-1.2%¥23.27¥23.39¥22.842,134,000
¥23.30-0.60-2.5%¥23.76¥23.85¥23.201,866,000
¥23.90+0.06+0.3%¥23.80¥24.23¥23.203,588,541
¥23.84+1.23+5.4%¥22.64¥24.20¥22.564,528,200
¥22.61+0.46+2.1%¥22.21¥22.75¥22.152,047,596
¥22.15-0.02-0.1%¥22.13¥22.38¥21.991,634,520
¥22.17+0.16+0.7%¥21.98¥22.19¥21.402,673,300
¥22.01-0.51-2.3%¥22.29¥22.96¥21.912,313,818
¥22.520.000.0%¥22.50¥22.65¥21.672,792,600
¥22.52-0.51-2.2%¥22.84¥23.29¥22.103,484,089
¥23.03+0.44+1.9%¥22.55¥23.14¥22.034,680,895
¥22.59+0.79+3.6%¥21.76¥22.65¥21.383,667,800
¥21.80-0.05-0.2%¥21.83¥22.00¥21.532,073,000
¥21.85-0.03-0.1%¥21.71¥22.20¥21.532,203,049
¥21.88-0.42-1.9%¥22.35¥22.80¥21.722,594,700
¥22.30-0.28-1.2%¥22.76¥22.88¥21.853,556,496
¥22.58+0.06+0.3%¥22.40¥22.72¥21.765,573,500
¥22.52-0.34-1.5%¥22.60¥24.25¥22.3110,746,255
¥22.86+2.08+10.0%¥20.14¥22.86¥20.1410,785,964
¥20.78+0.58+2.9%¥19.95¥21.16¥19.953,218,848
¥20.20+0.02+0.1%¥20.18¥20.35¥19.971,326,100
¥20.18+0.26+1.3%¥19.92¥20.38¥19.901,611,200
¥19.92+0.08+0.4%¥19.81¥20.16¥19.531,714,700
¥19.84-0.67-3.3%¥20.48¥20.74¥19.691,871,801
¥20.51-0.54-2.6%¥20.91¥21.03¥20.241,882,201
¥21.05+0.36+1.7%¥20.70¥21.38¥20.672,022,200
¥20.69-0.59-2.8%¥21.18¥21.38¥20.692,373,300
¥21.28-0.50-2.3%¥21.68¥21.91¥21.082,696,600
¥21.78+0.09+0.4%¥21.69¥21.99¥21.134,067,300
¥21.69-0.77-3.4%¥22.64¥22.64¥21.304,875,300
¥22.46+0.90+4.2%¥21.54¥22.88¥21.257,367,592
¥21.56+0.06+0.3%¥21.50¥22.08¥21.283,081,759
¥21.50-0.20-0.9%¥21.62¥21.71¥21.122,587,300
¥21.70+0.17+0.8%¥21.46¥22.36¥21.224,636,500
¥21.53-0.35-1.6%¥21.40¥21.78¥21.064,093,000
¥21.88-0.18-0.8%¥22.15¥22.49¥21.004,577,100
¥22.06-0.11-0.5%¥22.17¥23.26¥21.577,274,400
¥22.17+1.46+7.0%¥21.12¥22.40¥20.717,112,600
¥20.71+0.41+2.0%¥20.32¥21.48¥20.323,786,400
¥20.30+0.52+2.6%¥19.50¥20.58¥19.502,838,001
¥19.78-0.88-4.3%¥20.56¥20.85¥19.513,658,409
¥20.66+0.07+0.3%¥20.79¥21.05¥20.303,365,000
¥20.59+0.74+3.7%¥19.65¥21.36¥19.515,436,700
¥19.85+0.52+2.7%¥19.20¥20.15¥19.003,362,300
¥19.33-0.85-4.2%¥20.00¥20.18¥19.303,487,400
¥20.18-1.34-6.2%¥21.52¥21.58¥19.727,337,687
¥21.52+1.12+5.5%¥19.99¥21.87¥19.997,748,005
Ticker
Shanghai:600671
Asset type
Stock
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 22, 2026

Closed ¥23.90 (+0.3%) on Sep 22, 2026

Announcement on Progress in Providing Guarantee for Controlled Subsidiary

Sep 5, 2026

Closed ¥21.85 (-0.1%) on Sep 7, 2026

Announcement on Provision for Credit Impairment and Asset Impairment for the First Half of 2026

Aug 28, 2026

Closed ¥20.78 (+2.9%) on Aug 28, 2026

Announcement on the Public Solicitation of Transferees for the Controlling Shareholder's Proposed Transfer of Certain Shares of the Company through Public Solicitation and Agreement

Jul 23, 2026

Closed ¥20.18 (-6.2%) on Jul 23, 2026

Indicative Announcement on Proposed Transfer of Part of Company's Shares by Controlling Shareholder through Public Solicitation and Possible Change in Control

Jul 14, 2026

Closed ¥19.55 (-7.5%) on Jul 14, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Jun 30, 2026

Closed ¥16.88 (+1.6%) on Jun 30, 2026

Announcement on Reply to Letter of Supervision and Inquiry of 2025 Annual Report

Jun 19, 2026

Closed ¥18.34 (+2.1%) on Jun 22, 2026

Announcement on Resolutions of the 20th Meeting of the 12th Board of Directors

Jun 12, 2026

Closed ¥16.47 (+3.3%) on Jun 12, 2026

Announcement on Listing and Circulation of Shares Subject to Lock-Up from Shareholding Reform

May 30, 2026

Closed ¥17.82 (+2.1%) on Jun 1, 2026

Announcement on Convening Performance Briefing for 2025 and Q1 2026

May 14, 2026

Closed ¥19.11 (-1.6%) on May 14, 2026

All Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd news

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix

News releases
21 in the last 12 months · 58 in all · newest Sep 22, 2026 · oldest 2024

Log in to ask 6ix AI your own questions about Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd.